Related Experiment Videos
Increased bone morphogenetic protein-6 expression in mouse long bones after estrogen administration.
Andrea Plant1, Jonathan H Tobias
1Rheumatology Unit, University of Bristol Division of Medicine, United Kingdom.
Summary
High-dose estrogen stimulates bone formation in mice by increasing bone morphogenetic protein-6 (BMP-6) mRNA. This suggests BMP-6 may mediate estrogen's osteogenic effects, with BMP-6 positive stromal cells appearing near bone formation sites.
Area of Science:
- Endocrinology
- Bone Biology
- Molecular Biology
Background:
- High-dose estrogen administration is known to stimulate new bone formation in mouse long bones.
- Regulatory proteins play a crucial role in mediating estrogen's effects on bone metabolism.
Purpose of the Study:
- To investigate the role of regulatory proteins in estrogen-induced bone formation.
- To examine changes in femoral messenger RNA (mRNA) for candidate factors following estrogen administration.
Main Methods:
- Intact female mice received weekly injections of 17beta-estradiol (E2).
- Femoral mRNA levels were analyzed using Northern blot analysis at multiple time points post-injection.
- BMP-6 protein expression was assessed by immunocytochemistry and double immunolabeling in longitudinal femoral sections.
Main Results:
- Bone morphogenetic protein-6 (BMP-6) mRNA levels significantly increased at day 8 and subsequent time points after E2 administration.
- Estrogen treatment led to the emergence of BMP-6-positive stromal cells near active bone formation surfaces.
- These BMP-6-positive cells were distinct from osteoblast precursors and did not express leukocyte or erythroid markers.
Conclusions:
- Estrogen-induced osteogenesis in female mice is associated with increased BMP-6 mRNA levels.
- BMP-6-positive stromal cells appear adjacent to active bone formation surfaces following estrogen treatment.
- BMP-6 may function as a paracrine mediator of estrogen's osteogenic action in mice.